Back
Arcutis Biotherapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
ARQT
Arcutis Biotherapeutics
Last Price:
10.13
Seasonality Move:
101.78%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight selling pressure.
Arcutis Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.97 | Buy |
| 20-day SMA: | 9.64 | Buy |
| 50-day SMA: | 9.59 | Buy |
| 200-day SMA: | 9.5 | Buy |
| 8-day EMA: | 10.03 | Buy |
| 20-day EMA: | 9.79 | Buy |
| 50-day EMA: | 9.65 | Buy |
| 200-day EMA: | 9.16 | Buy |
Arcutis Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 55.7 | Buy |
| Chaikin Money Flow: | -485931 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.53 - 10.27) | Buy |
| Bollinger Bands (100): | (8.99 - 10.49) | Buy |
Arcutis Biotherapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arcutis Biotherapeutics Stock
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 10.14 while ARQT 8-day simple moving average is 9.97, which is a Buy signal.
- The stock price of ARQT is 10.14 while Arcutis Biotherapeutics 20-day SMA is 9.64, which makes it a Buy.
- Arcutis Biotherapeutics 50-day simple moving average is 9.59 while ARQT share price is 10.14, making it a Buy technically.
- ARQT stock price is 10.14 and Arcutis Biotherapeutics 200-day simple moving average is 9.50, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Sell
26
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy or a Sell?
-
Arcutis Biotherapeutics stock is rated a Sell
The current Arcutis Biotherapeutics [ARQT] share price is $10.14. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Arcutis Biotherapeutics Stock Info
Market Cap:
1.19B
Price in USD:
10.14
Share Volume:
1.11M
Arcutis Biotherapeutics 52-Week Range
52-Week High:
13.17
52-Week Low:
1.76
Sell
26
Arcutis Biotherapeutics (ARQT)
is a Sell
Arcutis Biotherapeutics Share Price Forecast
-
What is the Arcutis Biotherapeutics stock price today?
The Arcutis Biotherapeutics stock price is 10.14 USD today. -
Will ARQT stock go up or go down?
Arcutis Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Arcutis Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics is overvalued.
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 10.14 while ARQT 8-day exponential moving average is 10.03, which is a Buy signal.
- The stock price of ARQT is 10.14 while Arcutis Biotherapeutics 20-day EMA is 9.79, which makes it a Buy.
- Arcutis Biotherapeutics 50-day exponential moving average is 9.65 while ARQT share price is 10.14, making it a Buy technically.
- ARQT stock price is 10.14 and Arcutis Biotherapeutics 200-day simple moving average is 9.16, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics
Is Arcutis Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.
Technical Analysis of Arcutis Biotherapeutics
Should I short Arcutis Biotherapeutics stock?
- ARQT Moving Average Covergence Divergence (MACD) indicator is 0.21, suggesting Arcutis Biotherapeutics is a Buy
- Arcutis Biotherapeutics Relative Strength Index (RSI) is 55.7, which suggest Arcutis Biotherapeutics is overbought
- The Bollinger Bands (25) for Arcutis Biotherapeutics is (8.53 - 10.27), which suggest Arcutis Biotherapeutics is a Buy
- The Bollinger Bands (100) for Arcutis Biotherapeutics is (8.99 - 10.49), which suggest Arcutis Biotherapeutics is a Buy
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.